Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy
<div><p>Esophageal cancer (EC) is a disease often marked by aggressive growth and poor prognosis. Lack of targeted therapies, resistance to chemoradiation therapy, and distant metastases among patients with advanced disease account for the high mortality rate. The tumor microenvironment...
محفوظ في:
| المؤلف الرئيسي: | Ajaz A. Bhat (12984701) (author) |
|---|---|
| مؤلفون آخرون: | Sabah Nisar (12561961) (author), Selma Maacha (501715) (author), Tatiana Correa Carneiro-Lobo (18459033) (author), Sabah Akhtar (5809925) (author), Kodappully Sivaraman Siveen (9440771) (author), Nissar A. Wani (15070399) (author), Arshi Rizwan (18278773) (author), Puneet Bagga (4055866) (author), Mayank Singh (793077) (author), Ravinder Reddy (564813) (author), Shahab Uddin (154400) (author), Jean-Charles Grivel (284645) (author), Gyan Chand (452737) (author), Michael P. Frenneaux (9538623) (author), Mushtaq A. Siddiqi (18459036) (author), Davide Bedognetti (2632474) (author), Wael El-Rifai (303374) (author), Muzafar A. Macha (11605200) (author), Mohammad Haris (564809) (author) |
| منشور في: |
2021
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy
حسب: Ajaz A. Bhat (12984701)
منشور في: (2022) -
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
حسب: Kalyani Patil (2679424)
منشور في: (2022) -
Claudin-1, A Double-Edged Sword in Cancer
حسب: Ajaz A. Bhat (12984701)
منشور في: (2020) -
Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
حسب: Gh Rasool Bhat (13038132)
منشور في: (2024) -
The effect of novel nitrogen-based chalcone analogs on colorectal cancer cells: Insight into the molecular pathways
حسب: Arij Fouzat, Hassan
منشور في: (2024)